-transparent.png){kind=logo}
Treatment with 5-fluorouracil is common in oncological patients. Side effects on bone marrow, skin, and mucous membranes have been reported. Cardiotoxicity, which is less predictable, can be life-threatening. Manifestations include angina, arrhythmias, infarction, heart failure and cardiogenic shock. The toxic mechanisms that might be involved have been much discussed but have not yet been clearly established. Current evidence supports the possibility of a metabolic effect in common with the cascade secondary to ischemia due to coronary disease. Based on a case report, we discuss the usual clinical presentation, treatment and prognosis. Finally we make recommendations for managing patients being treated with 5-fluorouracil.
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
August 1989,
The Journal of the Oklahoma State Medical Association,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
January 2005,
Annals of Saudi medicine,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
February 1975,
Lancet (London, England),
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
September 1987,
The American journal of medicine,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
March 1987,
The American journal of medicine,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
May 1988,
Lakartidningen,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
January 2003,
Romanian journal of internal medicine = Revue roumaine de medecine interne,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
July 2017,
The American journal of emergency medicine,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
May 1973,
Journal of medicinal chemistry,
Juan Luján, and
Fernando García De Burgos, and
Alejandro Jordán, and
Miguel García, and
Fernando Reyes, and
María D Espinosa
January 2020,
Case reports in oncological medicine,
